INTENSITY THERAPEUTICS, INC. (INTS)
Data as of , from SEC Form 4 filings.
See up to 3 months of INTS. The 7-day demo opens the 1M and 3M ranges and puts INTS on your watchlist.
Start 7-day demoLatest INTS insider trades
About INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC. is an SEC registrant, filing under CIK 0001567264, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
INTS Form 4 activity by transaction type, last 90 days
No Form 4 activity for INTS in the last 90 days.
INTS insider transactions (Form 4)
1717 Form 4 filings on record, the earliest from Oct 23, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas I. H. Dubin - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | ||
| Mark A. Goldberg - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Stock Option (right to buy Common Stock) | 11,000 | $0.00 | - | |
| Grant or award | Stock Option (right to buy Common Stock) | 34,000 | $0.00 | - | ||
| Lewis H. Bender - Officer | Grant or award | Stock Option (right to buy Common Stock) | 78,000 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Common Stock, $0.0001 Par Value | 3,688 | $3.49 footnote F2 | $13K | |
| ||||||
| Grant or award | Common Stock, $0.0001 Par Value | 1,093 | $3.49 footnote F2 | $4K | ||
| ||||||
| Lewis H. Bender - Officer | Grant or award | Common Stock, $0.0001 Par Value | 37,749 footnote F1 | $6.11 | $231K | |
| ||||||
| John M. Wesolowski - Officer | Grant or award | Common Stock, $0.0001 Par Value | 69,745 | $0.26 | $18K | |
| Grant or award | Common Stock, $0.0001 Par Value | 14,179 | $0.26 | $4K | ||
| Mark A. Goldberg - Director | Grant or award | Stock Option (right to buy Common Stock) | 50,000 | $0.00 | - | |
| Lewis H. Bender - Officer | Grant or award | Stock Option (right to buy Common Stock) | 700,000 | $0.00 | - | |
| Thomas I. H. Dubin - Director | Grant or award | Stock Option (right to buy Common Stock) | 50,000 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Stock Option (right to buy Common Stock) | 70,028 | $0.00 | - | |
| Grant or award | Stock Option (right to buy Common Stock) | 427,379 | $0.00 | - | ||
INTS insider trading FAQ
What is the latest insider trade for INTS?
INTENSITY THERAPEUTICS, INC. (INTS) has filed no insider reports in the last 90 days. The most recent on record is dated 20 July 2026. The full record for INTS runs to 17 Form 4 filings, the earliest from 23 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INTS stock?
No insider purchases of INTS were filed in the last 90 days.
How many insiders are selling INTS stock?
No insider sales of INTS were filed in the last 90 days.
Where can I see INTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas I. H. Dubin view on EDGAR
- - Daniel Donovan view on EDGAR
- - Mark A. Goldberg view on EDGAR
- - Emer Leahy view on EDGAR
- - John M. Wesolowski view on EDGAR
- - Joseph Talamo view on EDGAR
- - Lewis H. Bender view on EDGAR
- - John M. Wesolowski view on EDGAR
- - Joseph Talamo view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INTS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INTS with a 7-day demo
- INTS on your watchlist
- Every INTS Form 4 filing on record
- Up to 3 months of INTS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive